Diaryl macrocyclic compound and pharmaceutical composition, and use thereof
AssigneePrimeGene (Beijing) Co., Ltd.
InventorsLi Zhu, Wei Wu, Yanqing Yang, Wei Hu
Life of this patent
Estimating the term…
Loading patent…
AssigneePrimeGene (Beijing) Co., Ltd.
InventorsLi Zhu, Wei Wu, Yanqing Yang, Wei Hu
Estimating the term…
The present invention provides a compound as represented by formula (1) or a pharmaceutically acceptable salt, a solvate, an active metabolite, a polymorph, an isotope label, an isomer or a prodrug thereof. The present invention also provides a pharmaceutical composition containing the same and the use of the compound and the pharmaceutical composition in preparation of drugs for treating tyrosine kinase-mediated diseases. The compound and the pharmaceutical composition comprising same provided by the present disclosure have significant tyrosine kinase inhibitory activity, can overcome tumor drug resistance, and break through blood-brain barrier, also have excellent pharmacokinetic properties and excellent oral bioavailability, and can be administered in a small dosage, thereby reducing treatment costs and possible side effects to a patient. Thus, the application potential is very great.
A compound of formula (1) or a pharmaceutically acceptable salt or isotope label thereof,
Dependencies are inferred from the claim text.